Related Experiment Video
Updated: May 1, 2026

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies
Published on: September 19, 2025
Biphasic modulation of cancer stem cell-driven solid tumour dynamics in response to reactivated replicative
J Poleszczuk1, P Hahnfeldt, H Enderling
1Center of Cancer Systems Biology, GRI, Tufts University School of Medicine, Boston, MA, 02135, USA; College of Inter-faculty Individual Studies in Mathematics and Natural Sciences, University of Warsaw, Warsaw, 02-089, Poland.
Objectives:
Cell senescence is a physiological programme of irreversible mitotic arrest that is triggered after a variety of intracellular and extracellular events. Its purpose is to protect tissue integrity by disabling mitosis in stressed or damaged cells. The senescence program serves as a tumour suppressor, and cancer cells are believed to bypass senescence to advance to malignancy. Recent studies have shown that senescence can be reactivated in cancer cells through a number of external perturbations, including oncogene activation, tumour suppressor gene withdrawal and irradiation.
Materials And Methods:
We have developed an agent-based model of solid tumour growth whose input population composition is based on the cancer stem-cell hypothesis. It is used to show how cancer stem cells can drive tumour progression, while non-stem cancer cells (CCs) interfere with this by impeding cancer stem-cell dynamics.
Results:
Here we show that intratumoural competition between the two cell types may arise to modulate tumour progression and ultimately cancer presentation risk. Model simulations reveal that reactivation of the replicative senescence programme in CCs initially increases total tumour burden, as attrition from cell death is partially averted, but evolves to provide tumour control in the long-term through increasing constraints on stem-cell compartment kinetics.
Conclusions:
Reactivation of replicative senescence can prolong CC competition with cancer stem cells, thereby ultimately inhibiting malignant progression regardless of tumour size.
Insights
Reactivating cell senescence in non-stem cancer cells can initially increase tumor size but ultimately controls tumor growth by limiting cancer stem cell activity, inhibiting malignant progression.
Area of Science:
- Cellular biology
- Cancer research
- Computational modeling
Background:
- Cell senescence is a natural process of irreversible cell cycle arrest that prevents damaged cells from dividing, acting as a tumor suppressor mechanism.
- Cancer cells often evade senescence to promote malignancy, but recent research indicates senescence can be re-induced in cancer cells.
- The cancer stem-cell hypothesis suggests that a subpopulation of cancer stem cells drives tumor growth, while other cancer cells (CCs) may impede this process.
Purpose of the Study:
- To investigate the role of intratumoral competition between cancer stem cells and non-stem cancer cells (CCs) in tumor progression.
- To model how the reactivation of replicative senescence in CCs influences tumor dynamics and cancer presentation risk.
Main Methods:
- Development of an agent-based model simulating solid tumor growth.
- Model inputs are based on the cancer stem-cell hypothesis, incorporating dynamics between cancer stem cells and non-stem cancer cells (CCs).
- Simulations were performed to analyze the effects of reactivated senescence in CCs on tumor progression.
Main Results:
- Reactivation of replicative senescence in CCs initially leads to increased total tumor burden due to reduced cell death.
- Over the long term, this senescence reactivation curtails tumor growth by imposing constraints on the cancer stem cell compartment.
- Intratumoral competition between cell types modulates tumor progression and influences the risk of cancer presentation.
Conclusions:
- Reactivating replicative senescence in non-stem cancer cells prolongs their competition with cancer stem cells.
- This prolonged competition ultimately inhibits malignant progression, irrespective of the initial tumor size.
- Senescence reactivation emerges as a potential strategy for long-term tumor control.
More Related Videos
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
11:21Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
Published on: January 26, 2019
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Replicative Cell Senescence
Replicative Cell Senescence
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells